All Updates

All Updates

icon
Filter
Partnerships
MilliporeSigma and The Michael J. Fox Foundation partner to advance Parkinson's research
Precision Medicine
Jun 18, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Precision Medicine

Precision Medicine

Jun 18, 2024

MilliporeSigma and The Michael J. Fox Foundation partner to advance Parkinson's research

Partnerships

  • MilliporeSigma and The Michael J. Fox Foundation for Parkinson's Research (MJFF) have partnered to research treatments to slow down the progression of Parkinson's disease (PD).

  • According to the partnership, MilliporeSigma will use its SMCxPRO immunoassay technology to detect low levels of pS65 ubiquitin, a biomarker associated with cell dysfunction in PD patients. This technology will help track the response of different therapeutic options on disease progression, potentially contributing to improved quality of life for patients. The study will be funded by MJFF. 

  • MilliporeSigma, Merck KGaA's life science business, was formed from the merger of EMD Millipore and Sigma-Aldrich. It offers a comprehensive portfolio of life sciences products, including biochemicals, labware, and equipment for various scientific and industrial applications. MilliporeSigma focuses on accelerating access to health by providing tools for research, drug discovery, development, and manufacturing.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.